论文部分内容阅读
目的:探讨喜炎平注射液联合利巴韦林治疗小儿病毒性肺炎和小儿病毒性肠炎伴发热患儿的临床治疗效果及应用价值。方法:选择我院儿科2012年1月~2013年1月收治的小儿病毒性肺炎和小儿病毒性肠炎患儿80例,所有患儿伴有不同程度的发热,将所有患儿随机分为2组,对照组40例给予单纯利巴韦林治疗,观察组40例在给予利巴韦林治疗的基础上给予患儿喜炎平注射液治疗,比较两种治疗方案对病毒性肺炎和病毒性肠炎的治疗效果及两组小儿的退热时间及住院时间。结果:观察组患儿病毒性肺炎和病毒性肠炎的治疗有效率分别为96%、93.33%明显高于对照组患儿70.83%和62.50%,差异有统计学意义(P<0.05)。观察组患儿退热时间及住院时间均短于对照组,经统计学分析比较,差异有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:采用喜炎平注射液联合利巴韦林治疗小儿病毒性肺炎和小儿病毒性肠炎伴发热疗效显著,能够缩短退热时间和住院时间,值得在临床大力推广使用。
Objective: To investigate the clinical effect and application value of Xiyanping injection combined with ribavirin in treating children with viral pneumonia and pediatric viral enteritis with fever. Methods: Eighty children with viral pneumonia and infantile viral enteritis were admitted to our pediatric department from January 2012 to January 2013. All children were accompanied with varying degrees of fever, and all children were randomly divided into two groups , 40 cases in the control group were treated with ribavirin alone, and 40 cases in the observation group were treated with Xiyanping injection on the basis of ribavirin treatment. The effects of the two treatment regimens on viral pneumonia and viral enteritis The treatment effect and two groups of children’s antipyretic time and hospital stay. Results: The effective rates of viral pneumonia and viral enteritis in the observation group were 96% and 93.33%, respectively, which were significantly higher than those in the control group (70.83% and 62.50%, P <0.05). The observation group patients with fever and hospitalization time were shorter than the control group, the statistical analysis, the difference was statistically significant (P <0.05). The incidence of adverse reactions in the two groups, the difference was not statistically significant (P> 0.05). Conclusion: Xiyanping injection combined with ribavirin treatment of children with viral pneumonia and viral infection in children with significant effect of fever, can reduce the time of fever and hospital stay, it is worth in the clinic to promote the use of.